Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Enpicom

Enpicom
2015 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Owner and operator of a dynamic biomedical software development company intended to bring innovative products to the market in the field of immunogenomics. The company's product includes an innovative T-cell receptor and B-cell receptor repertoire analysis platform that support development, guidance and monitoring of immunotherapies and provides simple and powerful analysis of immune repertoire sequencing data, enabling users to improve their life and health.

Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare
Other Industries
Other Software
Business/Productivity Software
Primary Office
  • Science Park 402
  • 1098 XH Amsterdam
  • Netherlands

+31 020 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Enpicom’s full profile, request a free trial.

Enpicom Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. Loan Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Enpicom Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
ACE Venture Lab Accelerator/Incubator 000 0000 000000 0

Enpicom Executive Team (3)

Name Title Board
Seat
Contact
Info
Jos Lunenberg Chief Executive Officer
Alvise Trevisan Chief Technology Officer & Co-Founder
Nicola Bonzanni Co-Founder & Chief Scientific Officer